Colorectal cancer patient outcome is influenced by tumour-adherent bacteria through epigenetic regulation of cardinal genes including PHLPP1
Objective How tumour-adherent microbiome can influence outcomes in patients with colorectal cancer (CRC).Methods and analysis CRC tissues (n=97) were analysed using RNAseq, whole exome sequencing (WES) and 16 r sRNA sequencing. Inflammatory/immune cells were quantified by immunohistochemistry in mic...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | BMJ Oncology |
| Online Access: | https://bmjoncology.bmj.com/content/4/1/e000859.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849729737942892544 |
|---|---|
| author | Mathias Chamaillard Khashayarsha Khazaie Cécile Charpy Iradj Sobhani Aurelien Amiot Nilmara De Oliveiro Alves Emma Bergsten Caroline Barau Amaury Vaysse Shatha Awaad Mohammad Sadeghi Denis Mestivier |
| author_facet | Mathias Chamaillard Khashayarsha Khazaie Cécile Charpy Iradj Sobhani Aurelien Amiot Nilmara De Oliveiro Alves Emma Bergsten Caroline Barau Amaury Vaysse Shatha Awaad Mohammad Sadeghi Denis Mestivier |
| author_sort | Mathias Chamaillard |
| collection | DOAJ |
| description | Objective How tumour-adherent microbiome can influence outcomes in patients with colorectal cancer (CRC).Methods and analysis CRC tissues (n=97) were analysed using RNAseq, whole exome sequencing (WES) and 16 r sRNA sequencing. Inflammatory/immune cells were quantified by immunohistochemistry in mice and human tissues. Patient outcomes were analysed according to virulent bacteria and gene RNA levels in tumour tissues. We performed faecal microbiota transfer (FMT) in germ-free mice using presurgery stool samples from nine patients with sporadic CRC. Changes in gene mutations and DNA methylation in the colonic mucosa were measured and compared with those in mice receiving FMT from nine healthy individuals. Immune cells in the tumour tissues of donor and mouse recipients were compared.Results FMT from CRC donors led to preferential DNA demethylation, but specific host genes, including pleckstrin homology domain and leucine-rich repeat protein phosphatase 1 (PHLPP1), were hypermethylated compared with FMT from healthy donors. CRC faecal samples showed elevated levels of virulent bacteria, reduced levels of commensals and triggered colon inflammation in mice. Notably, PHLPP1 was downregulated in CRC tumours, and its expression varied in accordance with other CRC cardinal genes (n=137, as identified in the scientific literature to be involved in colon carcinogenesis), and was most pronounced in inflammatory bowel disease associated CRC. Tumours with reduced PHLPP1 expression are more inflammatory and correspond to patients with a higher relative abundance of adherent virulent bacteria and poorer outcomes.Conclusion The composition of CRC tumour-adherent bacteria predicts epigenetic modifications and altered expression of cardinal CRC genes such as PHLPP1. PHLPP1 downregulation characterises patients with CRC with inflammatory tumours and poor survival outcomes. |
| format | Article |
| id | doaj-art-4ba8d671edb84592ab49c2128a31ee5a |
| institution | DOAJ |
| issn | 2752-7948 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Oncology |
| spelling | doaj-art-4ba8d671edb84592ab49c2128a31ee5a2025-08-20T03:09:05ZengBMJ Publishing GroupBMJ Oncology2752-79482025-07-014110.1136/bmjonc-2025-000859Colorectal cancer patient outcome is influenced by tumour-adherent bacteria through epigenetic regulation of cardinal genes including PHLPP1Mathias Chamaillard0Khashayarsha Khazaie1Cécile Charpy2Iradj Sobhani3Aurelien Amiot4Nilmara De Oliveiro Alves5Emma Bergsten6Caroline Barau7Amaury Vaysse8Shatha Awaad9Mohammad Sadeghi10Denis Mestivier113 Laboratoire de Physiologie Cellulaire INSERM U1003, Universite Lille, Lille, France4Mayo Clinic, Rochester, MN, USA1 Department of Pathology, CHU Henri Mondor, Créteil, FranceDepartment of Oncology and Transplantation, and Immunology-Gastroenterology Unit, University of Paris 12 and Henri Mondor Hospital AP-HP, Créteil, France1 Gastroenterology, CHU Bicêtre, Le Kremlin-Bicetre, France3 Laboratoire de Physiologie Cellulaire INSERM U1003, Universite Lille, Lille, France2 EA7375-EC2M3-University Research Team, UPEC, Créteil, Île-de-France, France5 Henri Mondor Hospital-Biology&Biobanks, Assistance Publique - Hopitaux de Paris, Paris, France6 Hub Bioinformatics, Institut Pasteur, Paris, Île-de-France, France7 Immunology of Cancer, Mayo Clinic, Rochester, Minnesota, USA8 EA7375-EC2M3 University Research Team, UPEC, Créteil, Île-de-France, France8 EA7375-EC2M3 University Research Team, UPEC, Créteil, Île-de-France, FranceObjective How tumour-adherent microbiome can influence outcomes in patients with colorectal cancer (CRC).Methods and analysis CRC tissues (n=97) were analysed using RNAseq, whole exome sequencing (WES) and 16 r sRNA sequencing. Inflammatory/immune cells were quantified by immunohistochemistry in mice and human tissues. Patient outcomes were analysed according to virulent bacteria and gene RNA levels in tumour tissues. We performed faecal microbiota transfer (FMT) in germ-free mice using presurgery stool samples from nine patients with sporadic CRC. Changes in gene mutations and DNA methylation in the colonic mucosa were measured and compared with those in mice receiving FMT from nine healthy individuals. Immune cells in the tumour tissues of donor and mouse recipients were compared.Results FMT from CRC donors led to preferential DNA demethylation, but specific host genes, including pleckstrin homology domain and leucine-rich repeat protein phosphatase 1 (PHLPP1), were hypermethylated compared with FMT from healthy donors. CRC faecal samples showed elevated levels of virulent bacteria, reduced levels of commensals and triggered colon inflammation in mice. Notably, PHLPP1 was downregulated in CRC tumours, and its expression varied in accordance with other CRC cardinal genes (n=137, as identified in the scientific literature to be involved in colon carcinogenesis), and was most pronounced in inflammatory bowel disease associated CRC. Tumours with reduced PHLPP1 expression are more inflammatory and correspond to patients with a higher relative abundance of adherent virulent bacteria and poorer outcomes.Conclusion The composition of CRC tumour-adherent bacteria predicts epigenetic modifications and altered expression of cardinal CRC genes such as PHLPP1. PHLPP1 downregulation characterises patients with CRC with inflammatory tumours and poor survival outcomes.https://bmjoncology.bmj.com/content/4/1/e000859.full |
| spellingShingle | Mathias Chamaillard Khashayarsha Khazaie Cécile Charpy Iradj Sobhani Aurelien Amiot Nilmara De Oliveiro Alves Emma Bergsten Caroline Barau Amaury Vaysse Shatha Awaad Mohammad Sadeghi Denis Mestivier Colorectal cancer patient outcome is influenced by tumour-adherent bacteria through epigenetic regulation of cardinal genes including PHLPP1 BMJ Oncology |
| title | Colorectal cancer patient outcome is influenced by tumour-adherent bacteria through epigenetic regulation of cardinal genes including PHLPP1 |
| title_full | Colorectal cancer patient outcome is influenced by tumour-adherent bacteria through epigenetic regulation of cardinal genes including PHLPP1 |
| title_fullStr | Colorectal cancer patient outcome is influenced by tumour-adherent bacteria through epigenetic regulation of cardinal genes including PHLPP1 |
| title_full_unstemmed | Colorectal cancer patient outcome is influenced by tumour-adherent bacteria through epigenetic regulation of cardinal genes including PHLPP1 |
| title_short | Colorectal cancer patient outcome is influenced by tumour-adherent bacteria through epigenetic regulation of cardinal genes including PHLPP1 |
| title_sort | colorectal cancer patient outcome is influenced by tumour adherent bacteria through epigenetic regulation of cardinal genes including phlpp1 |
| url | https://bmjoncology.bmj.com/content/4/1/e000859.full |
| work_keys_str_mv | AT mathiaschamaillard colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT khashayarshakhazaie colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT cecilecharpy colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT iradjsobhani colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT aurelienamiot colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT nilmaradeoliveiroalves colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT emmabergsten colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT carolinebarau colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT amauryvaysse colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT shathaawaad colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT mohammadsadeghi colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 AT denismestivier colorectalcancerpatientoutcomeisinfluencedbytumouradherentbacteriathroughepigeneticregulationofcardinalgenesincludingphlpp1 |